Dr. Johnson on Promise of Combination Therapy in Melanoma
4 Visningar
• 07/30/23
0
0
Bädda in
administrator
Prenumeranter
Douglas B. Johnson, MD, assistant professor of medicine, Vanderbilt University Medical Center, clinical director, Melanoma Research Program, Vanderbilt-Ingram Cancer Center, discusses the promise of combination therapy in patients with melanoma.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna